Brazil Anvisa–MFDS Cosmetics MoU 2026
Brazil’s 2026 Anvisa–MFDS Cosmetics MoU strengthens regulatory cooperation between Brazil and South Korea. The agreement focuses on cosmetics regulation, safety assessment, post-market surveillance, and regulatory alignment. By enhancing technical exchange and harmonization efforts, the partnership supports smoother market access and stronger public health oversight. The MoU updates a 2014 agreement and reflects growing global convergence in cosmetics regulatory frameworks.
Agência Nacional de Vigilância Sanitária (Anvisa) has signed a 2026 Memorandum of Understanding (MoU) with South Korea’s Ministry of Food and Drug Safety (MFDS), strengthening regulatory cooperation in cosmetics and public health oversight. The updated agreement builds on the 2014 partnership and enhances collaboration on cosmetics regulation, technical exchange, and regulatory innovation between Brazil and South Korea.
Key Updates in the 2026 Anvisa–MFDS MoU
The new MoU modernizes bilateral cooperation and introduces a stronger regulatory focus on cosmetics.
Main developments include:
Alignment of cosmetics regulatory standards
Exchange of technical and scientific expertise
Cooperation on safety assessment and post-market surveillance
Information sharing on regulatory innovation
Joint training and capacity-building initiatives
The agreement reflects growing regulatory complexity in the cosmetics sector, including innovative formulations, digital sales channels, and evolving safety expectations.
Impact on Cosmetics Market Access
Brazil is one of the world’s largest cosmetics markets, while South Korea is globally recognized for advanced skincare innovation. Regulatory alignment between Anvisa and MFDS may support:
Greater predictability for manufacturers
Reduced duplication in regulatory assessments
Improved clarity on compliance requirements
Strengthened post-market monitoring frameworks
For companies operating in both jurisdictions, closer regulatory dialogue can streamline market entry strategies and reduce compliance risks.
Broader Public Health and Regulatory Cooperation
Although cosmetics are a central focus, the MoU reinforces wider public health collaboration, including:
Technical meetings and expert exchanges
Sharing regulatory best practices
Cooperation in emerging health product challenges
Support for modern, science-based regulatory frameworks
Such cooperation contributes to global regulatory convergence and strengthens consumer protection systems.
How to Monitor and Comply
Companies exporting cosmetics to Brazil or South Korea should:
Review updated regulatory guidance issued by Anvisa and MFDS.
Monitor bilateral technical developments affecting ingredient safety and labeling.
Align internal compliance processes with evolving regulatory expectations.
Engage early with local regulatory representatives when planning new product launches.
Learn more about Brazil regulatory requirements via the official Anvisa portal.
External Reference
- Read the full announcement from Anvisa: Official Anvisa announcement
Internal Reference
Learn more about:
MarketANVISA Brazil Medical Device RegistrationResearch ReportAesthetic Devices: The 2026 Global Market-Access MapBlog ArticleHow to register medical devices and IVDs in BrazilResearch ReportContinuous Glucose Monitors: The Global Regulatory MapResearch ReportAI as a Medical Device: The Global Regulatory MapVideoBrazil’s UDI: Key Insights for Medical Device ManufacturersVideoHow to Register a Medical Device in BrazilMarket ServiceANVISA Brazil Medical Device & IVD Classification & GroupingMarket ServiceANVISA Brazil Medical Device Labeling RequirementsVideoHow to Register a Medical Device with the US FDALet's Talk,
Anywhere You Are.
Whether looking for more information or ready to partner with us, we're here to guide you through every step of the regulatory process.
Contact us